Is POLE p.Arg34Leu (c.101G>T) pathogenic?

POLE p.Arg34Leu (c.101G>T) is classified Uncertain significance in POLE (ClinVar, Multiple submitters, 6 submitters; last evaluated 2025-12-23). AlphaMissense: likely pathogenic (0.791); Very rare (popmax 0.00339%, nfe); Associated with hereditary neoplastic syndrome.

What condition is associated with POLE p.Arg34Leu (c.101G>T)?

POLE p.Arg34Leu (c.101G>T) is associated with hereditary neoplastic syndrome (ClinVar).

How common is POLE p.Arg34Leu (c.101G>T) in the general population?

POLE p.Arg34Leu (c.101G>T) is very rare (popmax 0.00339%, nfe) (gnomAD).

What do computational predictors say about POLE p.Arg34Leu (c.101G>T)?

AlphaMissense predicts likely pathogenic (score 0.791) — an in-silico prediction, not a clinical call.

POLE p.Arg34Leu

c.101G>T · rs747005851 · VCV405747

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 6 submitters

AlphaMissense

likely pathogenic

0.791 · ACMG-weighted

gnomAD v4.1

Rare

very rare (popmax 0.00339%, nfe)

Missense predictors

1/2 damaging

AlphaMissense, SaProt · REVEL no call

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense	0.791	likely pathogenic
REVEL	0.414	indeterminate
SaProt	LLR -6.42	tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 4.8	GERP 1.5, phastCons 1
Regional constraint	o/e 0.91	unconstrained · MANE · 23 kb · p 0.0025 · regional, not allelic
Overall
CADD	23.5	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.00339% European (non-Finnish) · 40/1,180,038 alleles

Filtering AF 0.00255% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00225%

Overall 0.00254% 41/1,614,076 alleles · very rare exomes 35/1,461,868 · genomes 6/152,208 · joint denominator

Ancestry group	Frequency	1 in
European (non-Finnish)grpmax	0.00339%	29,501
Admixed American	0.00167%	59,996

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: POLE
Protein: p.Arg34Leu
Coding: c.101G>T
MANE Select: NM_006231
dbSNP: rs747005851
Type: single nucleotide variant
Location: chr12:132681241 (GRCh38)
Gene constraint: LOEUF 0.75 · pLI <0.01 · ClinGen HI 1/3 (gnomAD)
Structure: AlphaFold pLDDT 80.32 · 18 PDB
Residue 34: an α-helix

Full POLE gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

POLE p.Arg34Cys Uncertain significance ★★ ⚠ same residue
POLE p.Arg34His Uncertain significance ★★ ⚠ same residue
POLE p.Arg34= Likely benign ★★ same residue
POLE p.Arg34Gly Uncertain significance ★ ⚠ same residue
POLE c.1686+32C>G Pathogenic/Likely pathogenic ★★ same condition
POLE p.Leu424Val Pathogenic ★★ same condition
POLE c.1020+5G>A Uncertain significance ★★ same condition
POLE c.1106+3G>C Uncertain significance ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pole-p-arg34leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown